Topics

Clinical Trials About "Zoetis and Nexvet Biopharma plc" RSS

22:53 EST 23rd February 2020 | BioPortfolio

We list hundreds of Clinical Trials about "Zoetis and Nexvet Biopharma plc" on BioPortfolio. We draw our references from global clinical trials data listed on ClinicalTrials.gov and refresh our database daily.

More Information about "Zoetis and Nexvet Biopharma plc" on BioPortfolio

We have published hundreds of Zoetis and Nexvet Biopharma plc news stories on BioPortfolio along with dozens of Zoetis and Nexvet Biopharma plc Clinical Trials and PubMed Articles about Zoetis and Nexvet Biopharma plc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Zoetis and Nexvet Biopharma plc Companies in our database. You can also find out about relevant Zoetis and Nexvet Biopharma plc Drugs and Medications on this site too.

Showing "Zoetis Nexvet Biopharma" Clinical Trials, all 4

Relevant

A Study of Orally Administered ZM-H1505R to Evaluate Safety, Tolerability and Pharmacokinetics After Single and Multiple Ascending Doses in Healthy Participants

ZM-H1505R is an investigational drug developed by Shanghai Zhimeng Biopharma Inc. for the treatment of Chronic Hepatitis B. The purpose of this study is to see how safe the study drug is and how well it is tolerated after dosing. The study will also test how the study drug is taken up and eliminated by the body. An additional part of the study is to look at how this could be changed by giving the study drug with food.


Single Ascending Dose Phase 1 Trial in Patients With Type 2 Diabetes

ARRY-403 is an investigational new drug being developed by Array BioPharma Inc. for treating Type 2 diabetes. The purpose of this study is to test the safety (potential side effects) and efficacy (potential effects) of the new study drug.

Probably Relevant

A Phase 1b Study Evaluating RESTEN-MP in Subjects With Focal de Novo Stenosis

The process of re-narrowing of a coronary artery following a revascularization procedure such as angioplasty, begins at the time of the procedure. Restenosis has long been considered a major problem for effective long-term interventional success. This often results in repeated procedures to deal with recurrent stenosis (or restenosis) of the original targeted vessel. There is a substantial body of literature suggesting that local MYC protein production in the injured c...


Safety and Efficacy of RESTEN-MP When Used in Conjunction With a Bare Metal Stent in Coronary Arteries

The process of re-narrowing of a coronary artery following a revascularization procedure such as angioplasty, begins at the time of the procedure. Restenosis has long been considered a major problem for effective long-term interventional success. This often results in repeated procedures to deal with recurrent stenosis (or restenosis) of the original targeted vessel. There is a substantial body of literature suggesting that local MYC protein production in the injured c...


More From BioPortfolio on "Zoetis and Nexvet Biopharma plc"

Quick Search